Director/PDMR Shareholding

RNS Number : 1109G

OptiBiotix Health PLC

25 March 2022

 

OptiBiotix Health plc

("OptiBiotix" or the "Company ")

PDMR Dealings

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, blood pressure and diabetes, ann o un ces   that it was notified today of the following share purchases made by René Kamminga, CEO of Optibiotix Ltd:

Date of transaction	Number of shares purchased	Price
23 March 2022	10,000	40p
24 March 2022	2,656	38p

Following the above transactions, Mr Kamminga is interested in 55,844 ordinary shares in the Company, representing 0.06 per cent. of the Company's issued share capital.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information, please contact:

OptiBiotix Health plc		www.optibiotix.com
Stephen O'Hara, Chief Executive	Contact via Walbrook below
Cairn Financial Advisers LLP (NOMAD)		Tel: [phone]
Liam Murray / Jo Turner / Ludovico Lazzaretti
Cenkos Securities plc (Broker)		Tel: [phone]
Callum Davidson / Neil McDonald
Michael Johnson / Russell Kerr (Sales)
Walbrook PR Ltd		Mob: [phone]
Anna Dunphy

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	René Kamminga
2	Reason for notification
a.	Position/Status	PDMR
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	OptiBiotix Health Plc
b.	LEI	213800UKYQFT941QHS14
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary shares of 2p each ISIN: GB00BP0RTP38
b.	Nature of the transaction	Purchase of 12,656 ordinary shares in the Company
c.	Price(s) and volume(s)
			Price(s) per share	Volume(s)
			40p 38p	10,000 2,656
d.	Aggregated information -  Volume -  Price	12,656 Average price of 39.6p
e.	Date of the transaction	23 and 24s March 2022
f.	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHSELFLIEESEDD